Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Barriers to Mammogram Completion Persist Despite Insurance Coverage and Reminder Programs

March 28th 2011

New research suggested that concern about pain may deter obese women from undergoing mammography, while a busy schedule may dissuade women aged less than 60 years

March 2011 OncLive Checkup

March 25th 2011

Editors' picks for this month's best Websites, news, resources, and online information for oncologists.

Insured Women Are Skipping Mammograms at High Rates

March 22nd 2011

About 40% of insured women in the United States are not undergoing screening mammography at least every 2 years in keeping with guidelines from the USPSTF.

NCCN 2011 Guidelines for Breast Cancer: Yes on Avastin, No on CYP2D6

March 21st 2011

As the Avastin (bevacizumab) drama continues at the FDA, the National Comprehensive Cancer Network (NCCN) has weighed in.

Dr. Pearlstone on Ongoing Research in Breast Cancer

March 16th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center, on important research taking place in the field of breast oncology.

The Final Word on CYP2D6 Testing and Tamoxifen?

March 16th 2011

CYP2D6 phenotype status does not predict tamoxifen efficacy in patients with early-stage breast cancer, according to a retrospective analysis of data from the Breast International Group

Shedding More Light on Identifying HER2

March 16th 2011

Breast cancer researcher Edith A. Perez, MD, is aiming to present more detailed study findings at national conferences later this year that will help clinicians better identify patients who would benefit from HER2 targeted treatment.

The Longstanding Quest for a Better Endocrine Therapy Continues High-Dose Fulvestrant: Have We Found Its Effective Dose, Combination, Setting, or Sequence?

March 15th 2011

Although several endocrine therapies are available today, the authors of this commentary contend that the quest for a better tamoxifen is ongoing.

Exercise, Weight-Lifting Help in Preventing Lymphedema

March 15th 2011

Two studies presented at SABCS refined knowledge about how to prevent lymphedema in patients with breast cancer.

Dr. Tripathy on Bone Health in Breast Cancer Patients

March 15th 2011

Debu Tripathy, MD, Co-leader Women's Breast Cancer Program at USC/Norris Comprehensive Cancer Center, on bone health considerations for patients with breast cancer.

Dr. Tripathy Discusses Bisphosphonate Studies

March 15th 2011

Debu Tripathy, MD, Co-leader Women’s Breast Cancer Program at USC/Norris Comprehensive Cancer Center, discusses clinical research and studies looking at the use of bisphosphonate for women with breast cancer.

Dr. Pearlstone on Biomarker Testing in the Community

March 14th 2011

David Pearlstone, MD, Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Biomarker Testing in the Community Setting

Dr. Pearlstone on Breast Cancer's 10 Year Progression

March 11th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Breast Cancer's Surgical Progression in the Past 10 Years

Dr. Osman on Detecting Malignant Breast Cancer

March 10th 2011

Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference Discusses Methods for Detecting Malignant Conditions in Breast Cancer

Dr. Pearlstone on Struggles Facing Breast Oncologists

March 10th 2011

David Pearlstone, MD, Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Struggles Facing Breast Oncologists

Dr. Pearlstone on Genomics and Personalized Medicine

March 10th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Genomics and Personalized Medicine

Dr. Pearlstone on his Role in Designing new Equipment

March 10th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center on his Role in Designing new Equipment

Diet and Lifestyle Are Factors in Breast Pain

March 10th 2011

Breast pain is among the most common reasons that women seek medical attention from a breast specialist.

Dr. Pearlstone on Current Biomarker Utilization

March 10th 2011

Dr. Pearlstone on Difficult Patient Conversations

March 10th 2011